Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5616804-(4-chlorobenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-amineMeSH

  an antineoplastic agent; structure in first source

• C5689444-(4-chlorophenoxy)-2-trichloromethylquinazolineMeSH

  an antimalarial; structure in first source

• C5747614-(4-chlorophenyl)-3-(3-(4-(4-(4-((4-(dimethylamino)-1-(phenylthio)but-2-yl)amino)-3-nitrophenylsulfonamido)phenyl)piperazin-1-yl)phenyl)-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acidMeSH

  structure in first source

• C5733334-(4-dimethylaminostyryl)-1-hexadecylpyridiniumMeSH

  structure in first source

• C5779484-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluorobenzamideMeSH

  has antibacterial activity; structure in first source

• C5603994-(4-ethylamino-(4-(N-ethylamino)-4'-(dimethylamino)stilbene))-1,4,7,10-tetraazacyclotridecane-11,13-dioneMeSH

  a fluorescent chemosensor for detecting cupric ion; structure in first source

• C5736384-(4-fluorobenzylcarbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl benzoateMeSH

  has anti-HIV activity; structure in first source

• C5749364-(4-fluorophenyl)amino-5,6,7-trimethoxyquinazolineMeSH

  has antineoplastic activity; structure in first source

• C5775674-(4-hept-1-enylphenoxy)butyric acidMeSH

  potentiates alpha7 acetylcholine receptor through partial activation of CamKII; structure in first source

• C5763994-(4-hydroxy-3-methoxybenzylidene)-1-(3-nitrophenyl)-3-phenyl-1H-pyrazol-5(4H)-oneMeSH

  a farnesoid X receptor antagonist and anticholesteremic agent; structure in first source

• C5736604-(4-hydroxy-3-methoxyphenylmethyl)curcuminMeSH

  has antineoplastic activity; structure in first source

• C5813744-(4-methoxyphenoxy)naphthalene-1,2-dioneMeSH

  structure in first source

• C5749874-(4-methyl-2-(methylamino)thiazol-5-yl)-2-(4-methyl-3-(morpholinosulfonyl)phenylamino)pyrimidine-5-carbonitrileMeSH

  structure in first source

• C5620734-(5-(1-methyl-1H-pyrrol-2-yl)-1,3,4-oxadiazol-2-yl)-1,4-diazabicyclo(3.2.2)nonaneMeSH

  an alpha7 nicotinic acetylcholine receptor agonist; structure in first source

• C5857404-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-4-hydroxy-N-(2-hydroxycyclopentyl)but-3-enamideMeSH

  structure in first source

• C5686544-(5-(4-bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1H-pyrazol-1-yl)-4-oxobutanoic acidMeSH

  structure in first source

• C5733434-(5-(4-hydroxy-3-methoxyphenyl)-3-oxopenta-1,4-dienyl)-2-methoxyphenolMeSH

  has antineoplastic activity; structure in first source

• C5758434-(5-(benzylthio)-1,3,4-oxadiazol-2-yl)-2-methoxyphenolMeSH

  structure in first source

• C5884174-(5-acetyloxy-8,8-dimethyl-6-(3-methylbut-2-en-1-yl)-4-oxo-4,8-dihydropyrano(2,3-f)chromen-3-yl)-1,2-phenylene diacetateMeSH

  an mTOR inhibitor; structure in first source

• C5736424-(5-chloro-2-hydroxybenzylideneamino)-N-(thiazol-2-yl)benzenesulfonamideMeSH

  has antibacterial activity; structure in first source

• C5842184-(5-chloro-3-(cyclohexylamino)imidazo(1,2-a)pyridin-2-yl)-2-methoxyphenolMeSH
• C5747624-(5-nitroindolin-1-yl)phenyl mannopyranosideMeSH

  an antibacterial agent that inhibits FimH protein; structure in first source

• C5712954-(5-thioxo-5H-1,2-dithiol-3-yl)-phenyl 2-(4-isobutyphenyl)propanoateMeSH

  a hydrogen sulfide-releasing NSAID with antineoplastic activity; structure in first source

• C5712924-(5-thioxo-5H-1,2-dithiol-3-yl)-phenyl 2-acetoxybenzoateMeSH

  a hydrogen sulfide-releasing NSAID with antineoplastic activity; structure in first source

• C5692924-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-(4-(2H-tetrazol-5-yl)butyl)piperidineMeSH

  inhibits L-PGDS

• C5857424-(6,7-dihydro-5H-indeno(5,6-d)thiazol-2-yl)benzene-1,3-diolMeSH

  structure in first soruce

• C5827254-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)methyl-2-phenyl-7-methoxybenzofuranMeSH

  structure in first source

• C5796454-(6-(azetidine-1-carbonyl)-5-fluoropyridin-3-yloxy)-2-ethyl-N-(5-methylpyrazin-2-yl)-2H-indazole-6-carboxamideMeSH

  structure in first source

• C5623634-(6-amino-9H-purin-9-yl)-7-(hydroxymethyl)spiro(2.4)heptane-5,6-diolMeSH

  an antiviral against hepatitis C virus; structure in first source

• C5688624-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinolineMeSH

  a GPR30 (GPER) antagonist with neuroprotective activity

• C5783414-(6-bromo-2-benzothiazolylazo)pyrogallolMeSH

  an acid-base indicator used for determination of the presence of Cu(II) and Pd(II); structure in first source

• C5714084-(6-methoxy-2-naphthyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazoleMeSH

  a Tie2 kinase inhibitor with antineoplastic activity

• C5735584-(7-(2-(4-chlorophenoxy)ethyl)-6-hydroxy-2-(methylamino)-7H-purin-8-yl)phenylphosphonic acidMeSH

  an eIF4E cap binding antagonist; structure in first source

• C5724674-(7-nitrobenzo(1,2,5)oxadiazole-4-yl)-1,7-dimethyl-1,4,7,10-tetra-azacyclododecaneMeSH

  structure in first source

• C5707894-(9-(tetrahydrofuran-3-yl))-8-(2,4,6-trifluorophenylamino)-9H-purin-2-ylaminocyclohexan-1-olMeSH
• C5715254-(N-(4-cyclohexylbenzyl)-2-(N,2,4,6-tetramethylphenylsulfonamido)acetamido)-2-hydroxybenzoic acidMeSH

  a STAT5-SH2 inhibitor with antileukemia activity; structure in first source

• C5815284-(aminomethyl)benzene sulfonateMeSH

  structure in first source

• C5692914-(benzo(b)thiophen-2-yl)-3-bromo-5-hydroxydihydrofuran-2(3H)-oneMeSH

  inhibits microsomal PGE synthase-1 (mPGES-1)

• C5781644-(benzyl-methyl-sulfamoyl)-N-(2-methyl-benzothiazol-5-yl)-benzamideMeSH

  structure in first source

• C5796464-(benzylcarbamoylmethyl)-2-(biphenyl-4-ylamino)-3-(5-tert-butyloxycarbamoyl-1-pentyl)-3,4-dihydroquinazolineMeSH

  structure in first source

• C5723624-(benzyloxy)-1-phenylbut-2-yn-1-olMeSH

  structure in first source

• C5784654-(bis(2-((methylsulfonyl)oxy)ethyl)amino)-2-methylbenzoic acidMeSH

  has antineoplastic activity; structure in first source

• C5863764-(but-3-enyl)oxyquinoloneMeSH

  structure in first source

• C5791234-(chlorophenyl)-(2-(3,5-dimethylpyrazol-1-yl)-9-methyl-9H-purin-6-yl)amineMeSH

  positive modulator of types 2 and 3 small conductance calcium-activated potassium channels; structure in first source

• C5852364-(diethylamino)-2-hydroxybenzaldehydeMeSH

  structure in first source

• C5779024-(difluoromethoxy)-N-(2-((4-(methoxymethyl)-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo(3,2-c)quinolin-1-yl)carbonyl)cyclohexyl)benzamideMeSH

  structure in first source

• C5793264-(ethylsulfonyl)-1-iodo-2-nitrobenzeneMeSH

  has antineoplastic activity; structure in first source

• C5723524-(guanin-9-yl)-3-hydroxypyrrolidin-1-N-ylcarbonylphosphonic acidMeSH

  structure in first source

• C5744514-(hexadecyloxy)-3-(2-(hydroxyimino)-3-oxobutanamido)benzoic acidMeSH

  structure in first source

• C5850574-(methylnitrosamino)-1-(3-pyridyl)-1-butanol N-glucuronideMeSH

  a urinary metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; structure in first source